Exane Derivatives’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$209K Hold
2,581
0.12% 157
2022
Q1
$226K Buy
2,581
+28
+1% +$2.37K 0.06% 302
2021
Q4
$231K Sell
2,553
-88
-3% -$7.61K 0.06% 313
2021
Q3
$221K Buy
2,641
+202
+8% +$17.5K 0.05% 373
2021
Q2
$207K Buy
2,439
+332
+16% +$26.8K 0.05% 383
2021
Q1
$162K Hold
2,107
0.05% 331
2020
Q4
$161K Sell
2,107
-119
-5% -$8.76K 0.05% 337
2020
Q3
$160K Sell
2,226
-1,700
-43% -$122K 0.05% 231
2020
Q2
$270K Sell
3,926
-2,707
-41% -$183K 0.07% 199
2020
Q1
$404K Buy
+6,633
New +$437K 0.11% 139

Other funds holding IXJ

Exane Derivatives's IXJ Position: Q2 2022 in Review

Exane Derivatives held its iShares Global Healthcare ETF (IXJ) position steady in Q2 2022 at 2,581 shares worth $209K. The position accounts for 0.12% of the portfolio, ranked #157.

Exane Derivatives first reported a position in IXJ in Q1 2020 and has held it in 10 quarters since. The position peaked at $404K in Q1 2020. 241 funds tracked by Wall St. Rank hold IXJ as of Q2 2022.

  • Exane Derivatives held 2,581 shares of iShares Global Healthcare ETF worth $209K as of Q2 2022.
  • Exane Derivatives left its iShares Global Healthcare ETF share count unchanged in Q2 2022.
  • iShares Global Healthcare ETF made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #157 holding.
  • Exane Derivatives first reported a position in iShares Global Healthcare ETF in Q1 2020 and has held it in 10 quarters since.
  • Exane Derivatives's iShares Global Healthcare ETF position peaked at $404K in Q1 2020.
  • 241 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.